Related Experiment Video
Updated: Jun 11, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
Prostaglandin signalling in cerebral ischaemia
1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA. kandreas@stanford.edu
Abstract:
The inducible cyclooxygenase COX-2 exerts neurotoxic effects in a wide spectrum of neurological disease models, including models of cerebral ischaemia and chronic neurodegeneration. As COX-1 and COX-2 catalyse the first committed step in prostaglandin synthesis, recent efforts have focused on identifying the downstream prostaglandin signalling pathways responsible for mediating the toxic effect of COX-2. Recent studies in models of in vitro excitotoxicity or hypoxia demonstrate that certain prostaglandin receptors mediate toxic effects, but a large number appear to mediate paradoxically protective effects. In vivo studies have begun to confirm initial in vitro findings, with selected prostaglandin receptors eliciting either neurotoxic or protective effects in models of cerebral ischaemia. In the present issue, Ikeda-Matsuo et al. examine the function of the PGE(2) EP3 receptor in a model of transient focal ischaemia and explore its potential signalling through Rho kinase activation.
Insights
Cyclooxygenase-2 (COX-2) causes neurotoxicity in neurological diseases. This study investigates the prostaglandin EP3 receptor
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- The enzyme cyclooxygenase-2 (COX-2) plays a role in neurological diseases, contributing to neurotoxicity.
- Prostaglandins, synthesized by COX enzymes, are key mediators in various biological processes, including neurological functions.
- Understanding downstream prostaglandin signaling is crucial for identifying therapeutic targets in neurological disorders.
Discussion:
- This research investigates the specific role of the prostaglandin E2 (PGE2) EP3 receptor in the context of cerebral ischemia.
- The study explores the signaling pathways potentially activated by the EP3 receptor, including Rho kinase activation.
- Investigating specific prostaglandin receptors helps elucidate their dual roles (neurotoxic or neuroprotective) in neurological conditions.
Key Insights:
- The inducible cyclooxygenase-2 (COX-2) contributes to neurotoxic effects observed in models of cerebral ischemia and neurodegeneration.
- While some prostaglandin receptors mediate toxic effects, others exhibit paradoxical protective roles in neurological disease models.
- The EP3 receptor's function in transient focal ischemia models and its potential Rho kinase signaling are examined.
Outlook:
- Further research into specific prostaglandin receptor functions can reveal novel therapeutic strategies for neurological diseases.
- Elucidating the precise signaling mechanisms of receptors like EP3 could lead to targeted interventions for conditions like stroke.
- This work contributes to a deeper understanding of the complex roles prostaglandins play in the central nervous system.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology

